ATXS vs ROL · rev $706.0K vs P/E 41, rev $1.99B
Astria Therapeutics Inc (ATXS) versus Rollins Inc (ROL) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported ROL revenue for 2026-06-30 was $1.99B. Net income was $251.7M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
ATXS currently screens at market cap $382.1M. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
Not investment advice. Open the ATXS and ROL stock pages for the full models.
Not investment advice.